Lithographic 3D Printed Biocompatible Polymer Scaffold
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing 3D cell cultures lack the ability to create structures that closely resemble physiological architectures, leading to inadequate reproduction of in vivo conditions, which limits the accuracy of experiments with cells, viruses, and substances, and results in insufficient vascularization and cell dedifferentiation.
Innovation Solution
A method involving lithographic 3D printing to create biocompatible polymer scaffolds with complex architectures, allowing for the colonization with biological cells, enabling the creation of 3D cell culture constructs that mimic physiological environments and support multiple cell types in a controlled manner.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If spheroids or microfluidic platforms are used to produce 3D cell cultures, then cell culture production is enabled, but the ability to create structures resembling physiological architectures is lost
Solution Approach 1:
The patent replaces conventional mechanical cell culture methods (spheroids, microfluidic platforms) with a lithographic 3D printing system that uses photopolymerization to create precise 3D scaffold structures. This substitution enables accurate reproduction of physiological architectures while maintaining ease of cell culture production through automated printing processes.
Solution Approach 2:
The patent changes the fundamental parameters of cell culture production by transitioning from 2D/1D conventional methods to 3D lithographic printing. This parameter change allows precise control over scaffold geometry, porosity, and internal structure, enabling creation of physiological architectures that were previously unachievable.
2Adaptability or versatility
If cells are randomly distributed in spheroids, then multiple cell types can be combined, but discrete positioning of cells is lost
Solution Approach 1:
The patent segments the scaffold structure into distinct regions with specific geometries, porosities, and material compositions. Each region can be independently designed to support particular cell types or functions, enabling both the combination of multiple cell types and their precise discrete positioning within the 3D structure.
Solution Approach 2:
The patent implements local quality by creating different regions within the scaffold with varying properties (porosity, material composition, geometry) tailored to specific cell types or functions. This allows precise control over cell positioning and interaction with the microenvironment while maintaining the ability to combine multiple cell types in a single construct.
3Ease of manufacture
If conventional 3D cell culture methods are used, then cell culture constructs can be produced, but vascularization and physiological conditions are insufficient
Solution Approach 1:
The patent incorporates porous structures within the scaffold that mimic the extracellular matrix and facilitate vascularization. The controlled porosity enables cell infiltration, nutrient transport, and angiogenesis, thereby improving vascularization and physiological condition representation while maintaining ease of construct production through automated printing.
Solution Approach 2:
The patent uses composite materials combining biocompatible polymers with functional additives to create scaffolds that better replicate physiological conditions. These composite structures provide mechanical support, biochemical cues, and structural complexity necessary for reliable vascularization and physiological function while remaining manufacturable through lithographic printing.
4Ease of manufacture
If simple scaffold structures are used, then manufacturing is easier, but ability to reproduce complex physiological architectures is reduced
Solution Approach 1:
The patent replaces manual or simple manufacturing methods with automated lithographic 3D printing, which can efficiently produce complex physiological architectures. The automated system handles the complexity of multi-layer printing, intricate geometries, and precise dimensional control, thereby enabling production of complex structures without proportionally increasing manufacturing difficulty.
Solution Approach 2:
The patent transitions from 2D or simple 3D printing to multi-layer 3D lithographic printing, adding the dimension of vertical layering and internal complexity. This dimensional approach enables creation of physiological architectures with intricate internal structures, varying porosities, and multi-scale features while maintaining manufacturability through systematic layer-by-layer construction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the production of highly reproducible and complex 3D cell culture constructs that accurately represent physiological conditions, facilitating experiments and reducing development costs by ensuring consistent results.
Implementation Method 1
constructing a 3D scaffold of a biocompatible polymer using a lithographic 3D printing method
Implementation Method 2
curing a photopolymerizable or photocrosslinkable substance by focusing an electromagnetic radiation in a focal plane
Data Source
AI summary
A 3D scaffold of a biocompatible polymer and colonized with biological cells is provided. The biological cells can be cultured to form a 3D cell culture construct that closely approximates a physiological architecture. A method for producing the 3D scaffold colonized with biological cells is also provided.